BGI Genomics

300676

Current ValuationThe current P/E ratio is -29.47, below the reasonable range, cheaper than 86.42% of the time in the past 5 years, and the industry ranks 64/84, the industry Median 21.22.

-29.47xP/E
Stock price¥38.39Earnings per share¥-1.30

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 21.22x
023466992

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 21.22x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
300122SZZHIFEI-BIOL
-2.19x91.91%¥30.83B
688180SHJunshi Biosciences
-71.47x81.90%¥30.64B
603392SHWantai Biological
-64.30x22.02%¥29.30B
688192SHDizal Pharmaceutical
-43.15x255.85%¥25.76B
300676SZBGI Genomics
-29.47x118.23%¥16.06B
688520SHSinocelltech
-16.59x171.21%¥14.88B
688319SHOlymvax Biopharmaceuticals
-321.71x227.87%¥10.30B
688765SHHEALTHGEN BIOTECH
-72.15x--¥10.22B
688806SHTrinomab Pharmaceutical
-21.90x--¥9.86B
688062SHMabwell
-9.08x37.63%¥9.54B
300204SZStaidson BioPharm
-92.34x--¥9.19B
688137SHNovoprotein
-93.51x--¥9.05B
688443SHGenrix Bio
-14.90x32.19%¥8.38B
688382SHInventisBio
-20.05x5.45%¥7.60B
002030SZDAJY
-9.95x--¥7.40B
688177SHBIO-THERA
-15.90x2.47%¥7.01B
300294SZBOYA BIOLOGY
-41.65x281.82%¥6.99B
688759SHBeBetter Med
-34.00x12.50%¥6.72B
688276SHBCHT
-32.67x66.67%¥6.53B
002038SZSL PHARM
-6.14x--¥5.15B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.